Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SCYNEXIS INC Director's Dealing 2021

Jan 26, 2021

34648_dirs_2021-01-26_63f1a681-6a03-4f3c-9101-3e36b5ee5072.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: SCYNEXIS INC (SCYX)
CIK: 0001178253
Period of Report: 2020-12-21

Reporting Person: PERCEPTIVE ADVISORS LLC (10% Owner)
Reporting Person: PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (10% Owner)
Reporting Person: EDELMAN JOSEPH (10% Owner)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 2400000 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Warrant (Right to Buy) $7.33 2021-12-21 Common Stock (1200000) Indirect
Warrant (Right to Buy) $8.25 2024-05-21 Common Stock (1200000) Indirect

Footnotes

F1: The securities are directly held by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"). Perceptive Advisors LLC (the "Advisor") serves as the investment manager of the Master Fund. The Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of its indirect pecuniary interest therein, and this report shall not be deemed an admission that the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Joseph Edelman, the managing member of the Advisor, serves as a director of the Issuer and has filed a separate Form 3.

F2: The warrants cannot be exercised if the Reporting Persons would beneficially own more than 9.9% of the Issuer's common stock upon the exercise of the warrant.